Overview

Ramelteon and Citicoline for Delirium

Status:
Withdrawn
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
Primary aim of this study is to assess the feasibility of conducting clinical research for delirium (confusion due to medical problems) at Clements University Hospital in Dallas, Texas. A secondary aim is to assess whether an FDA-approved sleeping aid called Ramelteon or an over-the-counter supplement called Citicoline are safe and beneficial in delirium.
Phase:
Phase 4
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Treatments:
Cytidine Diphosphate Choline